Path: /organizations/london-brain-bank
Type: Research Infrastructure / Brain Bank
Location: London, UK (UCL Queen Square)
Founded: 1991
Host Institution: UCL Queen Square Institute of Neurology
Website: londonbrainbank.org.uk
The London Brain Bank (also known as the UCL Brain Bank or Queen Square Brain Bank) is the UK's premier tissue repository for neurodegenerative disease research, established in 1991 as part of the UCL Institute of Neurology. Located at Queen Square in central London, it provides researchers worldwide with access to meticulously characterized human brain tissue for studies of Alzheimer's disease, Parkinson's disease, Progressive Supranuclear Palsy, and related neurodegenerative disorders.
The bank holds one of the largest and best-characterized collections of tauopathy tissue in the world, making it an invaluable resource for researchers studying 4R-tauopathies including PSP, corticobasal syndrome, and related disorders.
¶ History and Foundation
Established in 1991, the London Brain Bank was among the first purpose-built brain banks in the UK dedicated to neurodegenerative disease research. It grew from the collaborative effort of UCL neurologists and neuropathologists at the National Hospital for Neurology and Neurosurgery, leveraging Queen Square's deep expertise in movement disorders and dementia.
¶ Collection and Holdings
The bank maintains:
- Fixed tissue: Paraffin-embedded blocks from all major brain regions
- Frozen tissue: Fresh-frozen tissue stored at -80C for molecular/biochemical studies
- Fresh frozen sections: Rapidly frozen tissue for RNA/DNA extraction
- Fixed slabs: Large-format tissue sections for regional mapping
- CSF samples: Matched cerebrospinal fluid from many donors
Comprehensive sampling includes:
- Frontal cortex (BA9, BA46)
- Temporal cortex (entorhinal cortex, hippocampus)
- Parietal cortex
- Occipital cortex
- Basal ganglia (caudate, putamen, globus pallidus)
- Subthalamic nucleus
- Brainstem (subtantia nigra, locus coeruleus)
- Cerebellum (including dentate nucleus)
- Spinal cord
The collection includes extensive tissue from:
- 2,000+ brain donations
- 500+ PSP cases (one of the world's largest PSP collections)
- 600+ AD cases with varying Braak stages
- 400+ PD/LBD cases
- Extensive longitudinally-followed cases with clinical data
The London Brain Bank's PSP collection has been instrumental in:
- Establishing the distribution patterns of 4R tau in PSP
- Characterizing the different PSP subtypes (Richardson syndrome, PSP-PAGF, PSP-CBS, etc.)
- Studying the relationship between tau pathology and clinical phenotype
- Investigating tau propagation mechanisms in 4R-tauopathies
- Developing and validating immunohistochemical methods for PSP diagnosis
¶ Neuropathological Standards
The bank has contributed to establishing:
- Consensus diagnostic criteria for PSP
- Standardized sampling protocols for tauopathies
- Quality assurance standards for brain bank operations
- Digital pathology workflows for tissue-based research
Tissue from the bank has been used to validate:
- Neurofilament light chain (NfL) as a progression marker
- Tau PET imaging findings against postmortem data
- Fluid biomarkers from matched antemortem CSF/blood samples
The bank serves qualified researchers from academic institutions and biopharma companies worldwide. Applications are reviewed for:
- Scientific merit and potential to advance understanding of neurodegenerative disease
- Feasibility given available tissue
- Quality of research methodology
- Initial inquiry: Submit research proposal describing tissue needs
- Application review: Tissue committee reviews scientific merit (typically 4-6 weeks)
- Material transfer agreement: MTA required before tissue release
- Tissue preparation: Bank prepares tissue to specifications
- Delivery: Tissue shipped with full clinical and pathological documentation
Nominal processing and handling fees apply to cover operational costs. Fee schedule available upon request.
The London Brain Bank tissue has been used in landmark studies including:
- PSP staging systems: Characterization of regional tau burden across PSP subtypes
- Tau antibody validation: AT8, CP13, and other tau antibodies validated on bank tissue
- Genetic-epathological correlations: Mapping genotype-phenotype relationships in tauopathies
- PET-to-autopsy studies: Correlating in vivo tau PET signal with postmortem burden
- Cellular pathology: Detailed cellular mapping of tau pathology distribution
The London Brain Bank is integrated with: